Development and evaluation of diclofenac sodium thermorevesible subcutaneous drug delivery system

Plasma concentration (μg/ml) of diclofenac sodium at various time intervals after subcutaneous injection of commercial diclofenac sodium injection and DS in situ gels. The objective of current work was to develop and evaluate thermoreversible subcutaneous drug delivery system for diclofenac sodium....

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics Vol. 439; no. 1-2; pp. 120 - 126
Main Authors: Nasir, Fazli, Iqbal, Zafar, Khan, Jamshaid A., Khan, Abad, Khuda, Fazli, Ahmad, Lateef, Khan, Amirzada, Khan, Abbas, Dayoo, Abdullah, Roohullah
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 15-12-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Plasma concentration (μg/ml) of diclofenac sodium at various time intervals after subcutaneous injection of commercial diclofenac sodium injection and DS in situ gels. The objective of current work was to develop and evaluate thermoreversible subcutaneous drug delivery system for diclofenac sodium. The poloxamer 407, methyl cellulose, hydroxypropyl methyl cellulose and polyethylene glycol were used alone and in combination in different ratios to design the delivery system. The physical properties like Tsol–gel, viscosity, clarity of solution and gel were evaluated. The in vitro release of the drug delivery system was evaluated using membrane less method and the drug release kinetics and mechanism was predicted by applying various mathematical models to the in vitro dissolution data. Rabbits were used as in vivo model following subcutaneous injection to predict various pharmacokinetics parameters by applying Pk-Summit software. The in vitro and in vivo data revealed that the system consisting of the poloxamer 407 in concentration of 20% (DP20) was the most capable formulation for extending the drug release and maintaining therapeutic blood level of DS for longer duration (144h). The data obtained for drug content after autoclaving the solutions indicate that autoclaving results in 6% degradation of DS. The data also suggested that the studied polymers poloxamer, MC and PG are good candidate to extend the drug release possessing a unique thermoreversible property.
Bibliography:http://dx.doi.org/10.1016/j.ijpharm.2012.10.009
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2012.10.009